A proof-of-concept study in 10 patients with AML demonstrated variable expression of CXCR4, with five of ten patients exhibiting 68Ga-pentixafor uptake that correlated well with AML infiltration as determined by magnetic resonance imaging (134). The gene discussed is CXCR4; the disease is acute myeloid leukemia.